I’ve been hired as a freelance writer covering biotech companies for The Motley Fool, so posting frequency may drop off a little while I figure out my dual roles.  I think this blog has potential and I don’t want to see it die (actually I’d like to see it grow), so if there’s anyone out […]

Filed under: This blog | 13 Comments »